Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,047 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficient Large-Scale 2D Culture System for Human Induced Pluripotent Stem Cells and Differentiated Cardiomyocytes.
Tohyama S, Fujita J, Fujita C, Yamaguchi M, Kanaami S, Ohno R, Sakamoto K, Kodama M, Kurokawa J, Kanazawa H, Seki T, Kishino Y, Okada M, Nakajima K, Tanosaki S, Someya S, Hirano A, Kawaguchi S, Kobayashi E, Fukuda K. Tohyama S, et al. Among authors: yamaguchi m. Stem Cell Reports. 2017 Nov 14;9(5):1406-1414. doi: 10.1016/j.stemcr.2017.08.025. Epub 2017 Oct 5. Stem Cell Reports. 2017. PMID: 28988990 Free PMC article.
Insights from the international workshop on "Adapting agriculture to climate change and air pollution".
Agathokleous E, Emberson L, Pei J, Kobayashi K, Blande JD, Cook J, Fang C, Han Z, Ju H, Knopf O, Li T, Liu B, Liu X, Masui N, Masutomi Y, McHugh K, O'Neill C, Pande P, Rasheed MU, Ruhanen H, Shang B, Tai APK, Yamaguchi M, Yu Z, Yuan X, Xu Y, Zhao C, Zhao J, Zheng H, Zhou H, Feng Z. Agathokleous E, et al. Among authors: yamaguchi m. Environ Sci Pollut Res Int. 2024 Nov 20. doi: 10.1007/s11356-024-35549-z. Online ahead of print. Environ Sci Pollut Res Int. 2024. PMID: 39565480
A multicenter, phase II trial of triplet antiemetic therapy with palonosetron, aprepitant, and olanzapine for highly emetogenic chemotherapy in breast cancer (PATROL-II).
Suzuki K, Yokokawa T, Kawaguchi T, Takada S, Tamaki S, Kawasaki Y, Yamaguchi T, Koizumi K, Matsumoto T, Sakata Y, Arakawa Y, Ayuhara H, Hosonaga M, Yamaguchi M, Tsuji D. Suzuki K, et al. Among authors: yamaguchi m. Sci Rep. 2024 Nov 16;14(1):28271. doi: 10.1038/s41598-024-79781-6. Sci Rep. 2024. PMID: 39550497 Free PMC article. Clinical Trial.
6,047 results